Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
October 26, 2020

Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

Cancer Cell
Read more >
CTD²
October 12, 2020

Functional precision medicine identifies new therapeutic candidates for medulloblastoma

Cancer Research
Read more >
CTD²
October 05, 2020

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

The Journal of Clinical Investigation
Read more >
CTD²
October 01, 2020

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

EBioMedicine
Read more >
CTD²
September 28, 2020

Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

JCO Precision Oncology
Read more >
CTD²
September 14, 2020

Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses

Nature Biotechnology
Read more >
CTD²
September 03, 2020

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Cell
Read more >
CTD²
September 01, 2020

High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients

Journal of Translational Medicine
Read more >
CTD²
September 01, 2020

Plasticity of ether lipids promotes ferroptosis susceptibility and evasion

Nature
Read more >
CTD²
August 20, 2020

The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Nat Immunol.
Read more >

Pages

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated: November 25, 2020

Content on this page maintained by the Office of Cancer Genomics

CSVXML